United States (US)

PGCB antibody

Cat No. GTX14784

Host Rabbit
Clonality Polyclonal
Isotype IgG
Application WB
Reactivity Human, Rat

Application Note

WB: Use at a dilution of 1/500. Detects a band of approximately 120-122 kDa. Optimal dilutions/concentrations should be determined by the end user.




Preservative: None Constituents: Glycerol, Sodium chloride, HEPES


Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.


Synthetic C terminal peptide for particulate guanylyl cyclase B. (unfortunately, the amino acid sequence is considered to be commercially sensitive). All peptides were amidated for conjugation.


Immunogen affinity purified
The antibodies are affinity purified against immobilized antigen based affinity chromatography that yielded epitope-specific antibodies.




For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.


Cyclic GMP (cGMP), a key messenger in several signal transduction pathways, the intracellular levels of cGMP are maintained by the activity of opposing enzymes: synthesizing gualylyl cyclases (GC) and hydrolyzing phosphodiesterases (PDEs). The synthesizing enzymes (GCs) are found in two forms: cytosolic (soluble) and membrane-bound (particulate), while they share similar structural characteristics, they differ in their mechanisms of physiological regulations. Most importantly, soluble GC (sGC) contains a heme group and binds NO that activates the enzyme, while particulate GC (PGCs) are stimulated by natriuretic peptides. Particulate forms of guanylyl cyclases have been shown to function as natriuretic peptide receptors. In response to G-protein coupled receptor stimulation, the cGMP can be produced from GTP by either soluble guanylate cyclase (sGC), or by PGC. The sGC are heterodimers that are stimulated by nitric oxide and carbon monoxide or by particulate membrane-bound guanylyl cyclases which are activated by a complex mechanism by natriuretic peptides. PGCs have 7 different isoforms, PGCA through PGCG and are expressed in most tissues in isoform specific manner. There is significant structural homology among various PGCs, there is a large N-terminal extracellular domain (ECD), a single TMD and a large intracellular domain with protein kinase activity (KLD), a C-terminal catalytic domain (CD) and in between is a dimmerization domain (DD). Guanylyl cyclase B (PGCB) is a receptor for B type brain natriuretic peptide (BNP) and is 78% identical to PGCA in the ECD but only 43% in the CD. The binding of a ligand to the extra-cellular domain of PGCB triggers signal that control central and peripheral cardiovascular homoeostasis. Both PGCA and PGCB are phosphorylated at Serine residues in the KLD. Non-ionic detergents stimulated particulate guanylate cyclase activity in cerebral cortex of rat 8 to 12 fold while stimulation of soluble enzyme was 1.3 to 2.5 fold.
Package List Price ($)
$ 319